Giuseppe
Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
I Bonmarin (
)<SUP>1</SUP>, E Belchior<SUP>1</SUP>, Y Le Strat<SUP>1</SUP>, D L?vy-Bruhl<SUP>1</SUP>
Citation style for this article: Bonmarin I, Belchior E, Le Strat Y, L?vy-Bruhl D. First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12. Euro Surveill. 2012;17(18)
ii=20163. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20163
Date of submission: 30 March 2012 <HR>Following a suspected virus-vaccine mismatch, the screening method was used to estimate in almost real time the influenza vaccine effectiveness (VE) against severe cases in high-risk individuals. Data on vaccination status were provided by the influenza severe surveillance system and data on vaccination coverage by the National Social Security Scheme. The analysis showed a decline of the vaccine effectiveness in 2011/12 (VE: 30% (95% CI: 22?39)) compared to 2010/11 (VE: 53% (95% CI: 40?67)).
- ------
Eurosurveillance, Volume 17, Issue 18, 03 May 2012
Rapid communications
First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12
Rapid communications
First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12
I Bonmarin (
- D?partement des maladies infectieuses, Institut de veille sanitaire, Saint-Maurice, France
Citation style for this article: Bonmarin I, Belchior E, Le Strat Y, L?vy-Bruhl D. First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12. Euro Surveill. 2012;17(18)
ii=20163. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20163 Date of submission: 30 March 2012 <HR>Following a suspected virus-vaccine mismatch, the screening method was used to estimate in almost real time the influenza vaccine effectiveness (VE) against severe cases in high-risk individuals. Data on vaccination status were provided by the influenza severe surveillance system and data on vaccination coverage by the National Social Security Scheme. The analysis showed a decline of the vaccine effectiveness in 2011/12 (VE: 30% (95% CI: 22?39)) compared to 2010/11 (VE: 53% (95% CI: 40?67)).